Cardiovascular devices are medical devices used to diagnose and treat cardiovascular diseases, which are conditions that affect the heart and blood vessels. These devices are critical for the treatment of patients with heart disease, as they can help improve heart function, reduce symptoms, and prevent complications. The cardiovascular devices market in Germany is likely to register a CAGR of over 5.4% 随着美元的增量增长 1.4 预测期内 10 亿 2023-2029.

该行业报告提供了德国市场的市场预测, 接下来是对产品的详细分析. The Germany market data on cardiovascular devices can be segmented by product: 主动脉和血管移植装置, 斑块切除装置, 心脏辅助装置, 心律管理装置, 心血管假体装置, 心血管手术设备, 凝块管理装置, 电生理学设备, 介入心脏病学, 周围血管装置, 人工心脏瓣膜. 在 2022, the interventional cardiology segment made up the largest share of revenue generated by the cardiovascular devices market.

The Germany cardiovascular devices market is highly competitive. The competitive landscape of the industry has also been examined along with the profiles of the key players Abbott Laboratories, Abiomed Inc, 乙. 布劳恩梅尔松根股份公司, Biosense Webster Inc, Biotronik AG, 波士顿科学公司, C. 右. Bard Inc., Cook Medical Inc, 爱德华兹生命科学公司, 皇家飞利浦公司, LivaNova PLC, MAQUET Holding B.V. & 钴. 公斤, Medtronic plc, 微型科学公司, Terumo Corporation, 瓦. L. 血块 & 联营公司.

以数据为中心的报告重点关注市场趋势, 各细分市场的现状和前景. 全面覆盖不同细分市场, 该报告对于现有参与者来说是宝贵的资产, 新进入者和未来投资者.

为什么购买这份报告?
▹ Get a detailed picture of the Germany Cardiovascular Devices Market
▹ Identify segments/areas to invest in over the forecast period in the Germany Cardiovascular Devices Market
▹ 了解竞争环境, 市场的领先参与者
▹ Excel 格式的市场预估，方便跨场景分析.
▹ 三个月的策略咨询和研究支持.
▹ 为单用户许可证提供打印验证.